Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma

Keyphrases

• Tumor 100%
• Mitomycin C 100%
• Upper Tract Urothelial Carcinoma 100%
• Bacillus Calmette-Guérin 100%
• Endoscopic Management 100%
• Kidney Preservation 100%
• Upper Tract Urothelial Cancer 100%
• Kidney-sparing Surgery 100%
• Renal Function 50%
• Systemic Therapy 50%
• Genomic Characterization 50%
• Armamentarium 50%
• Antegrade 50%
• Invasive Disease 50%
• Imaging Diagnosis 50%
• Laser Ablation 50%
• Low-risk Disease 50%
• Dwell Time 50%
• Sustained Effect 50%
• Fulguration 50%
• Upper Tract 50%
• Photodynamic Diagnosis 50%
• Urothelial 50%
• Adjuvant Management 50%
• Ureteroscopy 50%
• Ureteroscopic 50%
• Actionable mutations 50%
• Nephroureterectomy 50%
• Narrow Band Imaging 50%
• Organ Sparing Treatments 50%
• Electroresection 50%
• Chemoablation 50%
• Intracavitary Therapy 50%

Medicine and Dentistry

• Neoplasm 100%
• Mitomycin 100%
• Transitional Cell Carcinoma 100%
• Upper Urinary Tract 100%
• Urothelial Cancer 100%
• Mycobacterium Bovis BCG 100%
• Kidney Preservation 100%
• Diseases 100%
• Kidney Function 50%
• Conservative Treatment 50%
• Fulguration 50%
• Recurrent Disease 50%
• Systemic Therapy 50%
• Laser Surgery 50%
• Nephroureterectomy 50%
• Ureteroscopy 50%
• Narrow Band Imaging 50%
• Intracavitary Therapy 50%